Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$2.45 - $3.88 $39 - $62
16 Added 84.21%
35 $0
Q2 2022

Aug 15, 2022

BUY
$2.34 - $3.96 $44 - $75
19 New
19 $0
Q3 2021

Nov 15, 2021

SELL
$5.94 - $8.46 $3,564 - $5,076
-600 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$7.62 - $11.75 $3,048 - $4,700
-400 Reduced 40.0%
600 $5,000
Q1 2021

May 17, 2021

BUY
$9.85 - $19.22 $9,850 - $19,220
1,000 New
1,000 $11,000

Others Institutions Holding ELDN

About Eledon Pharmaceuticals, Inc.


  • Ticker ELDN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 13,756,800
  • Market Cap $60M
  • Description
  • Eledon Pharmaceuticals, Inc., clinical stage biopharmaceutical company, focuses on developing medicines for the patients living with autoimmune disease and amyotrophic lateral sclerosis (ALS), and requiring an organ or cell-based transplant. Its lead product candidate includes AT-1501, a humanized monoclonal antibody to target CD40 Ligand that i...
More about ELDN
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.